|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for PRKACB |
Basic gene info. | Gene symbol | PRKACB |
Gene name | protein kinase, cAMP-dependent, catalytic, beta | |
Synonyms | PKA C-beta|PKACB | |
Cytomap | UCSC genome browser: 1p31.1 | |
Genomic location | chr1 :84543744-84670979 | |
Type of gene | protein-coding | |
RefGenes | NM_001242857.2, NM_001242858.2,NM_001242859.2,NM_001242860.2,NM_001242861.2, NM_001242862.2,NM_001300915.1,NM_001300916.1,NM_001300917.1, NM_002731.3,NM_182948.3,NM_207578.2, | |
Ensembl id | ENSG00000142875 | |
Description | cAMP-dependent protein kinase catalytic beta subunit isoform 4abcAMP-dependent protein kinase catalytic subunit betaprotein kinase A catalytic subunit beta | |
Modification date | 20141207 | |
dbXrefs | MIM : 176892 | |
HGNC : HGNC | ||
Ensembl : ENSG00000142875 | ||
HPRD : 01482 | ||
Vega : OTTHUMG00000009975 | ||
Protein | UniProt: P22694 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_PRKACB | |
BioGPS: 5567 | ||
Gene Expression Atlas: ENSG00000142875 | ||
The Human Protein Atlas: ENSG00000142875 | ||
Pathway | NCI Pathway Interaction Database: PRKACB | |
KEGG: PRKACB | ||
REACTOME: PRKACB | ||
ConsensusPathDB | ||
Pathway Commons: PRKACB | ||
Metabolism | MetaCyc: PRKACB | |
HUMANCyc: PRKACB | ||
Regulation | Ensembl's Regulation: ENSG00000142875 | |
miRBase: chr1 :84,543,744-84,670,979 | ||
TargetScan: NM_001242857 | ||
cisRED: ENSG00000142875 | ||
Context | iHOP: PRKACB | |
cancer metabolism search in PubMed: PRKACB | ||
UCL Cancer Institute: PRKACB | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of PRKACB in cancer cell metabolism | 1. Chen Y, Gao Y, Tian Y, Tian DL (2013) PRKACB is downregulated in non‑small cell lung cancer and exogenous PRKACB inhibits proliferation and invasion of LTEP‑A2 cells. Oncology letters 5: 1803-1808. go to article |
Top |
Phenotypic Information for PRKACB(metabolism pathway, cancer, disease, phenome) |
![]() | |
Cancer | CGAP: PRKACB |
Familial Cancer Database: PRKACB |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
![]() | |
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS REACTOME_METABOLISM_OF_CARBOHYDRATES REACTOME_GLUCOSE_METABOLISM |
![]() | |
OMIM | 176892; gene. 176892; gene. |
Orphanet | |
Disease | KEGG Disease: PRKACB |
MedGen: PRKACB (Human Medical Genetics with Condition) | |
ClinVar: PRKACB | |
Phenotype | MGI: PRKACB (International Mouse Phenotyping Consortium) |
PhenomicDB: PRKACB |
Mutations for PRKACB |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
![]() |
- Statistics for Tissue and Mutation type | Top |
![]() |
- For Inter-chromosomal Variations |
There's no inter-chromosomal structural variation. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
![]() |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
ovary | PRKACB | chr1 | 84555703 | 84555723 | PRKACB | chr1 | 84565473 | 84565493 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
![]() |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows PRKACB related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
DA775505 | NEUROD6 | 1 | 140 | 7 | 31380207 | 31380346 | PRKACB | 139 | 554 | 1 | 84644858 | 84662339 | |
BF944829 | PRKACB | 58 | 270 | 1 | 84633057 | 84633274 | RYR3 | 260 | 452 | 15 | 34021153 | 34023790 | |
DA223586 | SLC25A44 | 1 | 387 | 1 | 156163908 | 156169881 | PRKACB | 386 | 527 | 1 | 84630378 | 84630519 |
![]() |
Top |
![]() |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   | 1 |   |   |   |   | 2 |   |   |   | 1 |   |   |   |   |   | 1 | |||
GAIN (# sample) |   | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 1 | |||
LOSS (# sample) |   |   |   |   |   |   | 2 |   |   |   | 1 |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
![]() |
|
![]() |
Top |
![]() |
Stat. for Non-Synonymous SNVs (# total SNVs=42) | (# total SNVs=14) |
![]() | ![]() |
(# total SNVs=1) | (# total SNVs=1) |
![]() | ![]() |
Top |
![]() |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr1:84663454-84663454 | p.W197R | 3 |
chr1:84649767-84649767 | p.I95M | 2 |
chr1:84644908-84644908 | p.E32G | 2 |
chr1:84649790-84649790 | p.F103S | 2 |
chr1:84662305-84662305 | p.P142P | 2 |
chr1:84700929-84700929 | p.E333Q | 2 |
chr1:84668371-84668371 | p.Y216* | 2 |
chr1:84647960-84647960 | p.K62K | 2 |
chr1:84668407-84668407 | p.L228L | 2 |
chr1:84679969-84679969 | p.T300M | 2 |
Top |
![]() |
|
![]() |
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 |   |   | 5 |   |   | 2 |   | 3 |   |   | 7 | 3 | 1 |   |   | 3 | 3 |   | 4 |
# mutation | 1 |   |   | 4 |   |   | 2 |   | 3 |   |   | 8 | 3 | 1 |   |   | 3 | 3 |   | 4 |
nonsynonymous SNV | 1 |   |   | 3 |   |   | 2 |   | 3 |   |   | 6 | 3 | 1 |   |   | 3 | 2 |   | 2 |
synonymous SNV |   |   |   | 1 |   |   |   |   |   |   |   | 2 |   |   |   |   |   | 1 |   | 2 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
![]() |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr1:84644908 | p.L215L,PRKACB | 2 |
chr1:84700929 | p.I216M,PRKACB | 2 |
chr1:84668407 | p.E20G,PRKACB | 2 |
chr1:84668410 | p.E320Q,PRKACB | 2 |
chr1:84650823 | p.G10V,PRKACB | 1 |
chr1:84679841 | p.H33Q | 1 |
chr1:84610143 | p.S21Y,PRKACB | 1 |
chr1:84650847 | p.M219I,PRKACB | 1 |
chr1:84679863 | p.A220V,PRKACB | 1 |
chr1:84641485 | p.P22S,PRKACB | 1 |
![]() |
![]() |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
![]() |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for PRKACB |
![]() |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
![]() |
![]() |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
![]() |
Top |
![]() |
* This plots show the correlation between CNV and gene expression. |
![]() | |
![]() |
Top |
Gene-Gene Network Information |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
![]() | |||||
CDHR3,CPB1,DACH1,DCLK1,DNASE2B,FAM107B,FTO, GPRIN3,GRIK1,IQSEC2,MACROD2,MAST4,PPP2R1B,PRKACB, SAMD13,SEMA6D,SESN3,SIAH3,SMOC2,TSPAN1,UCN3 | ACTR2,ADD3,AP3M1,ATP6V1A,CPD,CTBS,ERGIC2, ERO1L,FBXW2,HFE,ITGAV,NIPA1,PRKACB,RPE, SACM1L,SEC24A,SLC2A13,SLC41A2,SLC5A3,TMEM167A,ZNF518B | ||||
![]() | |||||
ABCD3,BCAS1,ENTPD5,EPB41L4B,FAM134B,FMO5,FPGT, GNG12,LRRC19,MAGI3,PDCD4,PRKACB,SAMD13,SOS2, SULT1B1,TMEM56,TRAK2,UGP2,USP53,ZNF774,ZNRF2 | ACOT13,SMIM14,FXYD3,GOLPH3L,IFT74,MAL2,METAP1, PCTP,PRKACB,SAMD13,SH3BGRL2,SLC35A3,SLC44A1,SNX7, SPTLC1,TMEM87A,VAV3,XK,ZNF124,ZNF681,ZNF845 |
![]() |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
![]() |
Top |
Pharmacological Information for PRKACB |
![]() |
DB Category | DB Name | DB's ID and Url link |
Chemistry | BindingDB | P22694; -. |
Chemistry | ChEMBL | CHEMBL2918; -. |
Chemistry | GuidetoPHARMACOLOGY | 1477; -. |
Chemistry | BindingDB | P22694; -. |
Chemistry | ChEMBL | CHEMBL2918; -. |
Chemistry | GuidetoPHARMACOLOGY | 1477; -. |
Organism-specific databases | PharmGKB | PA33749; -. |
Organism-specific databases | PharmGKB | PA33749; -. |
Organism-specific databases | CTD | 5567; -. |
Organism-specific databases | CTD | 5567; -. |
![]() |
* Gene Centered Interaction Network. |
![]() |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00125 | protein kinase, cAMP-dependent, catalytic, beta | approved; nutraceutical | L-Arginine | ![]() | ![]() |
DB00155 | protein kinase, cAMP-dependent, catalytic, beta | approved; nutraceutical | L-Citrulline | ![]() | ![]() |
DB00435 | protein kinase, cAMP-dependent, catalytic, beta | approved | Nitric Oxide | ![]() | ![]() |
DB00988 | protein kinase, cAMP-dependent, catalytic, beta | approved | Dopamine | ![]() | ![]() |
DB00171 | protein kinase, cAMP-dependent, catalytic, beta | approved; nutraceutical | Adenosine triphosphate | ![]() | ![]() |
DB00770 | protein kinase, cAMP-dependent, catalytic, beta | approved; investigational | Alprostadil | ![]() | ![]() |
DB00668 | protein kinase, cAMP-dependent, catalytic, beta | approved | Epinephrine | ![]() | ![]() |
DB00131 | protein kinase, cAMP-dependent, catalytic, beta | approved; nutraceutical | Adenosine monophosphate | ![]() | ![]() |
DB00396 | protein kinase, cAMP-dependent, catalytic, beta | approved | Progesterone | ![]() | ![]() |
DB00938 | protein kinase, cAMP-dependent, catalytic, beta | approved | Salmeterol | ![]() | ![]() |
Top |
Cross referenced IDs for PRKACB |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |